Literature DB >> 21195543

Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells.

C Lepage1, D Y Léger, J Bertrand, F Martin, J L Beneytout, B Liagre.   

Abstract

Previously, we demonstrated that diosgenin induced apoptosis in colorectal cancer cell lines HCT-116 and HT-29. HT-29 cells have been reported to be one of the most resistant colorectal cancer cell lines to TRAIL-induced apoptosis. In this study, we investigated the effect of diosgenin on TRAIL-induced apoptosis in HT-29 cells. We showed that diosgenin sensitizes HT-29 cells to TRAIL-induced apoptosis. Mechanisms underlying this sensitization mainly involved diosgenin-induced p38 MAPK pathway activation and subsequent DR5 overexpression. Furthermore, we showed that diosgenin alone, TRAIL alone or combination treatment increased COX-2 expression and that the use of a COX-2 inhibitor further increased apoptosis induction. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195543     DOI: 10.1016/j.canlet.2010.12.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

1.  Death receptor 5 and neuroproliferation.

Authors:  Yanli Niu; Yongqiang Li; Jianfeng Zang; Hongen Huang; Jiexin Deng; Zhanjun Cui; Dongming Yu; Jinbo Deng
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

2.  Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay.

Authors:  Mohammad Reza Hajizadeh; Najmeh Parvaz; Mahmood Barani; Alireza Khoshdel; Mohammad Ali Fahmidehkar; Mehdi Mahmoodi; Masoud Torkzadeh-Mahani
Journal:  Daru       Date:  2019-05-27       Impact factor: 3.117

3.  Role of SB203580 in the regulation of human esophageal cancer cells under the effection of Diosgenin.

Authors:  Weiliang Ding; Yancai Jiang; Yaping Jiang; Taofeng Zhu; Ying Xu; Wenjie Jiang; Wenjiao Zhu; Zhian Tang; Zhijun Ge; Tieliang Ma; Yongfei Tan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.

Authors:  Shunchao Yan; Xiujuan Qu; Chong'an Xu; Zhitu Zhu; Lingyun Zhang; Ling Xu; Na Song; Yuee Teng; Yunpeng Liu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-24       Impact factor: 4.553

Review 5.  Biotechnological strategies for the sustainable production of diosgenin from Dioscorea spp.

Authors:  Romaan Nazir; Vijay Kumar; Suphala Gupta; Padmanabh Dwivedi; Devendra Kumar Pandey; Abhijit Dey
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-06       Impact factor: 4.813

Review 6.  Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.

Authors:  Xiaoyun Dai; Jingwen Zhang; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-07

7.  ST3GAL2 knock-down decreases tumoral character of colorectal cancer cells in vitro and in vivo.

Authors:  Marlène Deschuyter; David Yannick Leger; Anne Verboom; Alain Chaunavel; Abderrahman Maftah; Jean-Michel Petit
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

8.  Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.

Authors:  Cheng Long; Juan Chen; Hua Zhou; Tao Jiang; Xiang Fang; Dong Hou; Ping Liu; Hong Duan
Journal:  Cell Cycle       Date:  2019-01-22       Impact factor: 4.534

9.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01

10.  Cytotoxic activity of standardized extracts, a fraction, and individual secondary metabolites from fenugreek seeds against SKOV-3, HeLa and MOLT-4 cell lines.

Authors:  Justyna Stefanowicz-Hajduk; Barbara Król-Kogus; Barbara Sparzak-Stefanowska; Katarzyna Kimel; J Renata Ochocka; Mirosława Krauze-Baranowska
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.